Osamu Kanno

836 total citations
26 papers, 689 citations indexed

About

Osamu Kanno is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Osamu Kanno has authored 26 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Pharmacology and 6 papers in Organic Chemistry. Recurrent topics in Osamu Kanno's work include Antibiotic Resistance in Bacteria (5 papers), EEG and Brain-Computer Interfaces (5 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Osamu Kanno is often cited by papers focused on Antibiotic Resistance in Bacteria (5 papers), EEG and Brain-Computer Interfaces (5 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Osamu Kanno collaborates with scholars based in Japan, Germany and United States. Osamu Kanno's co-authors include F. Dean Toste, Wataru Kuriyama, Cheol Hong Cheon, Isao Kawamoto, Kazuyuki Nakagome, P. Clarenbach, Z. Jane Wang, Mizuki Takahashi, Takahiro Yamane and Takahide Nishi and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Tetrahedron.

In The Last Decade

Osamu Kanno

26 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Osamu Kanno Japan 15 341 201 132 116 43 26 689
Masaki Meguro Japan 16 565 1.7× 284 1.4× 164 1.2× 28 0.2× 4 0.1× 27 971
James S. New United States 15 267 0.8× 288 1.4× 19 0.1× 30 0.3× 22 0.5× 30 740
Muhammad Asim Raza Basra Pakistan 14 178 0.5× 102 0.5× 11 0.1× 20 0.2× 33 0.8× 44 493
Linxiao Wang China 18 198 0.6× 248 1.2× 7 0.1× 30 0.3× 5 0.1× 46 593
Cristina Bellucci Italy 14 209 0.6× 308 1.5× 56 0.4× 23 0.2× 8 0.2× 41 516
Shanshan Gu China 12 76 0.2× 171 0.9× 27 0.2× 52 0.4× 27 0.6× 26 565
Jian Jeffrey Chen United States 14 247 0.7× 129 0.6× 35 0.3× 14 0.1× 11 0.3× 29 499
David A. Perrey United States 13 130 0.4× 113 0.6× 10 0.1× 142 1.2× 105 2.4× 21 374
Thierry Sifferlen Switzerland 15 291 0.9× 289 1.4× 16 0.1× 159 1.4× 136 3.2× 29 581
Luigi Stasi Italy 11 128 0.4× 118 0.6× 9 0.1× 46 0.4× 31 0.7× 20 325

Countries citing papers authored by Osamu Kanno

Since Specialization
Citations

This map shows the geographic impact of Osamu Kanno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osamu Kanno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osamu Kanno more than expected).

Fields of papers citing papers by Osamu Kanno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Osamu Kanno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osamu Kanno. The network helps show where Osamu Kanno may publish in the future.

Co-authorship network of co-authors of Osamu Kanno

This figure shows the co-authorship network connecting the top 25 collaborators of Osamu Kanno. A scholar is included among the top collaborators of Osamu Kanno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Osamu Kanno. Osamu Kanno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suzuki, Yamato, et al.. (2019). Novel mouse model for evaluating in vivo efficacy of xCT inhibitor. Journal of Pharmacological Sciences. 140(3). 242–247. 8 indexed citations
2.
Honma, Daisuke, Osamu Kanno, Jun Watanabe, et al.. (2017). Novel orally bioavailable EZH1/2 dual inhibitors with greater antitumor efficacy than an EZH2 selective inhibitor. Cancer Science. 108(10). 2069–2078. 107 indexed citations
3.
Kanno, Osamu, et al.. (2011). Regio‐ and Enantioselective Hydroamination of Dienes by Gold(I)/Menthol Cooperative Catalysis. Angewandte Chemie International Edition. 50(42). 9919–9922. 121 indexed citations
4.
Cheon, Cheol Hong, Osamu Kanno, & F. Dean Toste. (2011). Chiral Brønsted Acid from a Cationic Gold(I) Complex: Catalytic Enantioselective Protonation of Silyl Enol Ethers of Ketones. Journal of the American Chemical Society. 133(34). 13248–13251. 108 indexed citations
5.
Kanno, Osamu, Takahiro Yamane, Jun Tanaka, et al.. (2010). Discovery of potent and orally active tricyclic-based FBPase inhibitors. Bioorganic & Medicinal Chemistry. 18(14). 5346–5351. 9 indexed citations
6.
Takahashi, Mizuki, et al.. (2009). Synthesis, SAR, and X-ray structure of tricyclic compounds as potent FBPase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(20). 5909–5912. 26 indexed citations
7.
Takahashi, Mizuki, et al.. (2009). Structure-based drug design of tricyclic 8H-indeno[1,2-d][1,3]thiazoles as potent FBPase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(3). 1004–1007. 27 indexed citations
8.
Kawamoto, Isao, Osamu Kanno, Katsuhiko Kojima, et al.. (2003). Synthesis and Structure-activity Relationships of Novel Parenteral Carbapenems, CS-023 (R-115685) and Related Compounds Containing an Amidine Moiety. The Journal of Antibiotics. 56(6). 565–579. 25 indexed citations
9.
Takahashi, Nobuaki, Kazuyuki Nakagome, Osamu Kanno, et al.. (2002). Early Components of Event-Related Potentials Related to Semantic and Syntactic Processes in the Japanese Language. Brain Topography. 14(3). 169–177. 15 indexed citations
10.
Nakagome, Kazuyuki, et al.. (2001). A topographical study of ERP correlates of semantic and syntactic violations in the Japanese language using the multichannel EEG system. Psychophysiology. 38(2). 304–315. 25 indexed citations
11.
Kawamoto, Isao, et al.. (2001). Synthesis and Antibacterial Activity of Novel 1.BETA.-Methyl Carbapenems with Cycloalkylamine Moiety at the C-2 Position.. The Journal of Antibiotics. 54(12). 1080–1092. 2 indexed citations
12.
Kanno, Osamu, et al.. (2000). Efficient Syntheses of (S)-4-Hydroxy-2-pyrrolidinone Derivatives. Heterocycles. 53(1). 173–173. 20 indexed citations
13.
Kanno, Osamu, et al.. (2000). ChemInform Abstract: Synthesis and Biological Evaluation of Novel Tricyclic Carbapenems (Trinems).. ChemInform. 31(40). 1 indexed citations
14.
Nakagome, Kazuyuki, et al.. (2000). Effects of zolpidem and zopiclone on cognitive and attentional function in young healthy volunteers: An event‐related potential study. Psychiatry and Clinical Neurosciences. 54(1). 37–40. 7 indexed citations
15.
Kanno, Osamu, Tsukasa Sasaki, Hirofumi Watanabe, et al.. (2000). Comparison of the effects of zolpidem and triazolam on nocturnal sleep and sleep latency in the morning: A cross-over study in healthy young volunteers. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 24(6). 897–910. 18 indexed citations
16.
Kanno, Osamu, et al.. (1999). Synthesis and Biological Evaluation of New Oral Carbapenems with 1-Methyl-5-oxopyrrolidin-3-ylthio Moiety.. The Journal of Antibiotics. 52(10). 900–907. 3 indexed citations
17.
Nakajima, Toru, Makoto Uchiyama, Kayo Shibui, et al.. (1998). Human time production under constant routine. Psychiatry and Clinical Neurosciences. 52(2). 240–241. 10 indexed citations
18.
Nakagome, Kazuyuki, et al.. (1998). Overnight Effects of Triazolam on Cognitive Function: An Event-Related Potentials Study. Neuropsychobiology. 38(4). 232–240. 26 indexed citations
19.
Kanno, Osamu. (1987). Electroencephalographic Study of 137 Patients with Thalidomide Embryopathy. Psychiatry and Clinical Neurosciences. 41(2). 197–205. 8 indexed citations
20.
Kanno, Osamu, et al.. (1977). Dissociation of Sleep Stages Between the Two Hemispheres in a Case With Unilateral. Psychiatry and Clinical Neurosciences. 31(1). 69–75. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026